← Leaderboards
Praveen Bansal
Glsynthesis, Inc.
$1,272,143
Attributed
$2,544,286
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $710.2K · FY2016–20$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,544,286 · 2
By mechanism
R44$2,544,286 · 2
Top collaborators
- Donald Lee Melchior4 shared
Most similar at Glsynthesis, Inc.
Same institution · by research overlap
- Donald Lee Melchior$3,418,001
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroIn Vitro AssayFluorescenceInstrumentationInhibitor/AntagonistInfectionDrug DevelopmentDrug CandidateEncapsulatedExcisionGenerationsBioreactorsActive Biological TransportHigh Throughput ScreeningAbcg2 GeneDetergentsCellsDocumentationDrug IndustryDrug UsageCommercializationEquipment And Supply InventoriesAtp PhosphohydrolaseLarge Scale Production
Grant awards (4)
Development of a FRET based Bile Salt Export Pump Inhibition Liposomal Assay$684,797
R44 · FY2020 · GM · contact PI
Development of a FRET based Bile Salt Export Pump Inhibition Liposomal Assay$710,211
R44 · FY2019 · GM · contact PI
Development of a fluorescence ABCG2 liposomal multidrug transporter assay$551,369
R44 · FY2017 · GM
Development of a fluorescence ABCG2 liposomal multidrug transporter assay$597,909
R44 · FY2016 · GM